@AlbertBourla | 58,130 followers
There are currently no vaccines to help protect older adults from RSV, so I am pleased to share positive data from our Phase 3 trial investigating the first potential bivalent RSV vaccine for these people: on.pfizer.com/3cfSK2l

Tweet Engagement Stats

Stats are based upon replies and quotes of this tweet

Engagement Map


Replies and Quotes

Total of 19 replies and 3 quotes found
In reply to @AlbertBourla
You鈥檙e funny you think people still trust you enough that you can tweet updates.
In reply to @AlbertBourla
How do you sleep at night?
In reply to @AlbertBourla
The Saints are coming....ready to die
In reply to @AlbertBourla
Make vaccine makers liable for the injury and deaths caused by their products.
In reply to @AlbertBourla
How do you live with yourself
In reply to @AlbertBourla
trying to look more realistic, claiming 87.5% efficacy, I think, they think, they've caught on.
Release the @pfizer texts between you and @vonderleyen鉂楋笍
In reply to @AlbertBourla
Go back hell , u fukin demon of moll#ock
In reply to @AlbertBourla
Much Congratulations 馃憦馃徎 馃憦馃徎Sir
In reply to @AlbertBourla
Wow!!! Can't wait to line up to roll up my sleeve. Forget about nutrition, working out, positivity. The #Pfizer is coming to save me & the world. New religion #lucifer & glad my pastor told me about God youtu.be/z2UJ6vq3W58
In reply to @AlbertBourla
And this time you give a Guaranty for it??
In reply to @AlbertBourla
Go 馃枙馃ぁ馃枙 yourself with that noise
Good news from Pfizer on RSV vaccine
Over 3 replies and quotes not shown


No retweeters found
17 retweeters not shown
For access to this functionality a Trendsmap Explore subscription is required.

A Trendsmap Explore subscription provides full access to all available timeframes

Find out more

Thanks for trying our Trendsmap Pro demo.

For continued access, and to utliise the full functionality available, you'll need to subscribe to a Trendsmap Pro subscription.

Find out more

This account is already logged in to Trendsmap.
Your subscription allows access for one user. If you require access for more users, you can create additional subscriptions.
Please Contact us if you are interested in discussing discounts for 3+ users for your organisation, or have any other queries.